AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Emergent BioSolutions Inc. Director's Dealing 2016

Jun 8, 2016

32870_dirs_2016-06-07_fc78de1e-dd82-4ebb-8a1b-40f8734f92e8.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Emergent BioSolutions Inc. (EBS)
CIK: 0001367644
Period of Report: 2016-06-06

Reporting Person: JOULWAN GEORGE A (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-06-06	Common Stock	S	4700	$44.12	Disposed	20785	Direct

Footnotes

F1: Consists of vested restricted stock units granted under the Amended and Restated Emergent BioSolutions Inc. 2006 Stock Incentive Plan, as amended.

F2: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $44.10 to $44.15.